For the Inventor, By the Inventor

Enter assignee name

Ludwigshafen, Germany

Knoll Aktiengesellschaft

USPTO Granted Patents = 84

Trademarks = 1

Forward Citations = 1,217

Loading Chart...

Loading Chart...

147 inventors (with patents filed for the assignee):

Hermann Bujard (6 out of 27 patents)

Joerg Rosenberg (6 out of 34 patents)

Manfred Gossen (6 out of 20 patents)

4. Alan Martin Birch (6 out of 7 patents)

5. Bruce Jeremy Sargent (6 out of 10 patents)

6. Paul Rafferty (5 out of 22 patents)

7. Frank Kerrigan (4 out of 7 patents)

8. Heinz Einig (4 out of 8 patents)

9. David John Heal (4 out of 11 patents)

10. Paul Anthony Bradley (4 out of 5 patents)

11. Cynthia A Romerdahl (4 out of 12 patents)

12. Hans-Heinrich Gruenhagen (4 out of 4 patents)

13. Alan Smith (3 out of 21 patents)

14. Robert Brian Jones (3 out of 4 patents)

15. Sharon C Cheetham (3 out of 7 patents)

Core Competencies:

Medical Treatment

Therapeutic Agents

Pharmaceutical Mixture

Polypeptides

Thyroid Hormones

Dihydrodibenzisoquinolinediones

Isoquinoline Derivatives

Gene Expression

Sustained Release

Tetracycline Derivatives

Naphthyridinone Derivatives

4-Aminopyridines

84 patents: Sort by Forward Citations

1. 6617360 - Medical treatment (2003-09-09),

2. 6608025 - Human NESP55 polypeptides, polynucleotides and uses thereof (2003-08-19),

3. 6509493 - Method for producing atropic acid ethyl ester (2003-01-21),

4. 6500830 - Conversion of modification D to modification A of doxazosin mesylate (2002-12-31),

5. 6458842 - Liquid pharmaceutical compositions comprising thyroid hormones (2002-10-01),

6. 6353002 - Therapeutic agents (2002-03-05),

7. 6326496 - Process for preparing an intermediate in the production of paroxetine (2001-12-04),

8. 6312687 - Stabilized lactoperoxidase and glucose oxidase concentrate (2001-11-06),

9. 6251945 - Pharmaceutical mixture comprising a combination of a profen and other active compounds (2001-06-26),

10. 6239165 - Liquid pharmaceutical formulation containing zotepine (2001-05-29),

11. 6235281 - Use of anti-TNF antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6 (2001-05-22),

12. 6225469 - Process for the preparation of 7-alkoxyalkyl-1,2,4-triazolo[1,5-A] pyrimidine derivatives (2001-05-01),

13. 6218405 - Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them (2001-04-17),

14. 6215001 - Imidazole derivatives as therapeutic agents (2001-04-10),

15. 6201004 - Dioxino derivatives and their use as therapeutic agents (2001-03-13),

Knoll Aktiengesellschaft is a leading global furniture design and manufacturing company. With a history spanning over 80 years, Knoll is renowned for its innovative and timeless designs. The company offers a wide range of furniture products including office systems, seating, tables, and textiles. Knoll's commitment to quality craftsmanship and sustainable practices has earned it a strong reputation in the industry. Headquartered in Germany, Knoll operates globally through its network of subsidiaries and partners.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

84 Patents

#8 in Ludwigshafen

#685 in Germany

#9,039 in the World

Ludwigshafen, Germany

Knoll Aktiengesellschaft

Forward Citations = 1,217

147 inventors:

Hermann Bujard (6 out of 27 patents)

Joerg Rosenberg (6 out of 34 patents)

Manfred Gossen (6 out of 20 patents)

4. Alan Martin Birch (6 out of 7 patents)

5. Bruce Jeremy Sargent (6 out of 10 patents)

Please report any incorrect information to [email protected]

Loading…